GAS2 and colorectal cancer: On the contrary, the dominant negative form of GAS2 (GAS2DN) has the ability to release the inhibitory effect of both GAS2 and Calpastatin on calpain [12], and it inhibits the in vitro growth of HCT116 cells (colorectal cancer) by activating calpain to degrade beta-catenin [13].